BACKGROUND: Standard, generic self-help materials have been largely ineffective as behavioral treatments for smoking cessation. In contrast, self-help programs tailored to the needs of specific smokers have shown promise in facilitating quitting. OBJECTIVE: To evaluate the incremental efficacy of the Committed Quitters Program (CQP), a set of computer-tailored materials offered to purchasers of nicotine polacrilex gum, compared with a briefuntailored user's guide and audiotape, both as supplements to nicotine replacement therapy. METHODS: We conducted a randomized, open-label trial with 3 parallel arms. Subjects were smokers who purchased 2- or 4-mg nicotine polacrilex gum and called the CQP toll-free enrollment line. Three thousand six hundred twenty-seven subjects consented to participate in 1 of 3 study arms: (1) those receiving the CQP materials (CQP group, n= 1,217), (2) those receiving CQP materials and an outbound telephone call (CQP + C group, n= 1,207); and (3) those receiving no supplemental intervention beyond the user's guide and audiotape that were prepackaged with the nicotine polacrilex gum (UG group, n= 1,203). Twenty-eight-day continuous abstinence rates were assessed by telephone interviews at 6 weeks and 10-week continuous rates at 12 weeks into treatment. RESULTS:Abstinence rates among respondents at the 6- and 12-week assessments were significantly higher for the CQP (36.2% and 27.6%) and CQP + C (35.5% and 27.3%) groups compared with the UG group (24.7% and 17.7%) at both intervals. The quit rates for the CQP and CQP + C groups were almost identical. CONCLUSIONS: The CQP proved to be an effective behavioral treatment, enhancing quit rates over and above nicotine replacement therapy and a brief untailored written guide and audiotape.
RCT Entities:
BACKGROUND: Standard, generic self-help materials have been largely ineffective as behavioral treatments for smoking cessation. In contrast, self-help programs tailored to the needs of specific smokers have shown promise in facilitating quitting. OBJECTIVE: To evaluate the incremental efficacy of the Committed Quitters Program (CQP), a set of computer-tailored materials offered to purchasers of nicotinepolacrilex gum, compared with a briefuntailored user's guide and audiotape, both as supplements to nicotine replacement therapy. METHODS: We conducted a randomized, open-label trial with 3 parallel arms. Subjects were smokers who purchased 2- or 4-mg nicotinepolacrilex gum and called the CQP toll-free enrollment line. Three thousand six hundred twenty-seven subjects consented to participate in 1 of 3 study arms: (1) those receiving the CQP materials (CQP group, n= 1,217), (2) those receiving CQP materials and an outbound telephone call (CQP + C group, n= 1,207); and (3) those receiving no supplemental intervention beyond the user's guide and audiotape that were prepackaged with the nicotinepolacrilex gum (UG group, n= 1,203). Twenty-eight-day continuous abstinence rates were assessed by telephone interviews at 6 weeks and 10-week continuous rates at 12 weeks into treatment. RESULTS: Abstinence rates among respondents at the 6- and 12-week assessments were significantly higher for the CQP (36.2% and 27.6%) and CQP + C (35.5% and 27.3%) groups compared with the UG group (24.7% and 17.7%) at both intervals. The quit rates for the CQP and CQP + C groups were almost identical. CONCLUSIONS: The CQP proved to be an effective behavioral treatment, enhancing quit rates over and above nicotine replacement therapy and a brief untailored written guide and audiotape.
Authors: Saul Shiffman; Sarah M Scholl; Jason Mao; Stuart G Ferguson; Donald Hedeker; Brian Primack; Hilary A Tindle Journal: Nicotine Tob Res Date: 2020-03-16 Impact factor: 4.244
Authors: Danielle E McCarthy; Thomas M Piasecki; Douglas E Jorenby; Daniel L Lawrence; Saul Shiffman; Timothy B Baker Journal: Addiction Date: 2010-09-15 Impact factor: 6.526
Authors: Lisa Sanderson Cox; Ana-Paula Cupertino; Laura M Mussulman; Niaman Nazir; K Allen Greiner; Jonathan D Mahnken; Jasjit S Ahluwalia; Edward F Ellerbeck Journal: Prev Med Date: 2008-05-03 Impact factor: 4.018
Authors: Heather L Coley; Rajani S Sadasivam; Jessica H Williams; Julie E Volkman; Yu-Mei Schoenberger; Connie L Kohler; Heather Sobko; Midge N Ray; Jeroan J Allison; Daniel E Ford; Gregg H Gilbert; Thomas K Houston Journal: Am J Prev Med Date: 2013-11 Impact factor: 5.043
Authors: Amanda L Graham; Sarah Cha; George D Papandonatos; Nathan K Cobb; Aaron Mushro; Ye Fang; Raymond S Niaura; David B Abrams Journal: Trials Date: 2013-02-17 Impact factor: 2.279